{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:42:05Z","timestamp":1748367725579,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Joint Cape Higher Education Consortium- Western Cape Government Grant","award":["Awarded to the School of Public Health at University of the Western Cape and the School of Public Health and Family Medicine at University of Cape Town"],"award-info":[{"award-number":["Awarded to the School of Public Health at University of the Western Cape and the School of Public Health and Family Medicine at University of Cape Town"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-019-7312-1","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T13:02:27Z","timestamp":1564146147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Perspectives on contraceptive implant use in women living with HIV in Cape Town, South Africa: a qualitative study among primary healthcare providers and stakeholders"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-1302","authenticated-orcid":false,"given":"Anna","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Harries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Morroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,26]]},"reference":[{"key":"7312_CR1","volume-title":"Consequences of unintended pregnancy","author":"SS Brown","year":"1995","unstructured":"Brown SS, Eisenberg L. Consequences of unintended pregnancy; 1995."},{"issue":"4","key":"7312_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1728-4465.2010.00250.x","volume":"41","author":"S Singh","year":"2010","unstructured":"Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plan. 2010;41(4):241\u201350.","journal-title":"Stud Fam Plan"},{"issue":"1","key":"7312_CR3","first-page":"95","volume":"2016","author":"N Lince-Deroche","year":"2016","unstructured":"Lince-Deroche N, et al. Achieving universal access to sexual and reproductive health services: the potential and pitfalls for contraceptive services in South Africa. South Afr Health Rev. 2016;2016(1):95\u2013108.","journal-title":"South Afr Health Rev"},{"key":"7312_CR4","unstructured":"Ross, J. and J. Stover, Use of modern contraception increases when more methods become available: analysis of evidence from 1982\u20132009. Global Health: Science and Practice, 2013: p. ghs1300010."},{"key":"7312_CR5","unstructured":"World Health Organization, Quality of care in contraceptive information and services, based on human rights standards: a checklist for health care providers. 2017."},{"issue":"11","key":"7312_CR6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2471\/BLT.08.059360","volume":"87","author":"R Wilcher","year":"2009","unstructured":"Wilcher R, Cates W. Reproductive choices for women with HIV. Bull World Health Organ. 2009;87(11):833\u20139.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"7312_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/01.olq.0000194602.01058.e1","volume":"33","author":"HW Reynolds","year":"2006","unstructured":"Reynolds HW, et al. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis. 2006;33(6):350\u20136.","journal-title":"Sex Transm Dis"},{"key":"7312_CR8","unstructured":"World Health Organization, PMTCT strategic vision 2010-2015: preventing mother-to-child transmission of HIV to reach the UNGASS and millennium development goals: moving towards the elimination of paediatric HIV, December 2009. 2010."},{"key":"7312_CR9","unstructured":"UNAIDS, Country Fact Sheet: South Africa 2016. 2016."},{"key":"7312_CR10","unstructured":"Statistics South Africa, South African demographic and health survey: key Indicator report. 2017."},{"key":"7312_CR11","unstructured":"Statistics South Africa, Mid-year population estimates. Statistics South Africa, 2017."},{"key":"7312_CR12","unstructured":"South African National Department of Health, National Contraception and Fertlity Planning Policy and Service Delivery Guidelines. 2012."},{"key":"7312_CR13","unstructured":"South African National Department of Health, National Contraception Clinical Guidelines. 2012."},{"key":"7312_CR14","unstructured":"World Health Organization, Medical eligibility criteria wheel for contraceptive use. 2015: Geneva."},{"issue":"3","key":"7312_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/AOG.0b013e31820ce2f0","volume":"117","author":"E Espey","year":"2011","unstructured":"Espey E, Ogburn T. Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol. 2011;117(3):705\u201319.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"7312_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.7196\/SAMJ.2017.v107i11.12805","volume":"107","author":"M Pleaner","year":"2017","unstructured":"Pleaner M, et al. Lessons learnt from the introduction of the contraceptive implant in South Africa. SAMJ. 2017;107(11):933\u20138.","journal-title":"SAMJ"},{"issue":"1","key":"7312_CR17","first-page":"11","volume":"1","author":"R Jacobstein","year":"2013","unstructured":"Jacobstein R, Stanley H. Contraceptive implants: providing better choice to meet growing family planning demand. Global Health. 2013;1(1):11\u20137.","journal-title":"Global Health"},{"issue":"10","key":"7312_CR18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.7196\/SAMJ.2017.v107i10.12821","volume":"107","author":"O Adeagbo","year":"2017","unstructured":"Adeagbo O, et al. Uptake and early removals of Implanon NXT in South Africa: perceptions and attitudes of healthcare workers. SAMJ. 2017;107(10):822\u20136.","journal-title":"SAMJ"},{"issue":"10","key":"7312_CR19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7196\/SAMJ.2017.v107i10.12833","volume":"107","author":"D Pillay","year":"2017","unstructured":"Pillay D, et al. User perspectives on Implanon NXT in South Africa: a survey of 12 public-sector facilities. S Afr Med J. 2017;107(10).","journal-title":"South African Medical Journal"},{"key":"7312_CR20","unstructured":"South African National Department of Health, Changes in the prescription of progestin subdermal implants (Implanon) in women who are taking enzyme iducing drugs such as efavirenz for HIV rifampicin for TB, and certain drugs used for epilepsy (carbamazepine, phenytoin, and phenobarbital): Dr Yogan Pillay (Deputy Director General), HIV\/AIDS, TB, MCWH Directorate., H.a. south African National Department of health, TB, MCWH directorate., editor. 2014."},{"issue":"4","key":"7312_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/QAI.0000000000000189","volume":"66","author":"CS Vieira","year":"2014","unstructured":"Vieira CS, et al. Effect of antiretroviral therapy including lopinavir\/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women. JAIDS J Acquir Immune Defic Syndr. 2014;66(4):378\u201385.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"5","key":"7312_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/QAD.0000000000000177","volume":"28","author":"SH Perry","year":"2014","unstructured":"Perry SH, et al. Implementing the Jadelle implant for women living with HIV in a resource-limited setting: concerns for drug interactions leading to unintended pregnancies. Aids. 2014;28(5):791\u20133.","journal-title":"Aids"},{"key":"7312_CR23","unstructured":"South African National Department of Health, Technical brief: drug interactions with progestin subdermal implants. 2014."},{"key":"7312_CR24","unstructured":"World Health Organization, Medical eligibility criteria for contraceptive use, fifth edition 2015. Full text and executive summary. 2015."},{"issue":"11","key":"7312_CR25","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2352-3018(15)00184-8","volume":"2","author":"RC Patel","year":"2015","unstructured":"Patel RC, et al. Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study. Lancet HIV. 2015;2(11):e474\u201382.","journal-title":"Lancet HIV"},{"issue":"17","key":"7312_CR26","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1097\/QAD.0000000000000827","volume":"29","author":"M Pyra","year":"2015","unstructured":"Pyra M, et al. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy. AIDS. 2015;29(17):2353\u20139.","journal-title":"AIDS"},{"issue":"1","key":"7312_CR27","doi-asserted-by":"publisher","first-page":"21396","DOI":"10.7448\/IAS.20.1.21396","volume":"20","author":"Rena C. Patel","year":"2017","unstructured":"Patel RC, et al. Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines. J Int AIDS Soc. 2017;20(1).","journal-title":"Journal of the International AIDS Society"},{"issue":"11","key":"7312_CR28","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1016\/S2352-3018(15)00204-0","volume":"2","author":"C Morroni","year":"2015","unstructured":"Morroni C, Bekker L-G, Rees H. Contraceptive implants and efavirenz-based ART: friend or foe? Lancet HIV. 2015;2(11):e454.","journal-title":"Lancet HIV"},{"issue":"11","key":"7312_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.7196\/SAMJ.2017.v107i11.12903","volume":"107","author":"H Rees","year":"2017","unstructured":"Rees H, et al. Strengthening implant provision and acceptance in South Africa with the \u2018any woman, any place, any time\u2019approach: an essential step towards reducing unintended pregnancies. S Afr Med J. 2017;107(11):939\u201344.","journal-title":"S Afr Med J"},{"key":"7312_CR30","unstructured":"Lipsky, M., Street-level bureaucracy, 30th ann. Ed.: dilemmas of the individual in public service. 2010: Russell Sage Foundation."},{"key":"7312_CR31","unstructured":"Gilson, L., Lipsky\u2019s street level bureaucracy. 2015."},{"key":"7312_CR32","unstructured":"World Health Organization, Consolidated guideline on sexual and reproductive health and rights of women living with HIV: executive summary. 2017."},{"key":"7312_CR33","unstructured":"World Health Organization, Ensuring human rights in the provision of contraceptive information and services: guidance and recommendations. 2014."},{"key":"7312_CR34","unstructured":"World Health Organization, Report on the public consultation to inform development of the framework on integrated people-centred health services. 2016, World Health Organization."},{"key":"7312_CR35","unstructured":"The World Health Organisation, Transition to new anti-retroviral drugs in HIV programmes: Clinical and Programmatic Considerations. 2017."},{"key":"7312_CR36","unstructured":"World Health Organization, Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2018, World Health Organization."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7312-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-7312-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7312-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T23:08:26Z","timestamp":1595632106000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-7312-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["7312"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-7312-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2019,7,26]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval to conduct this study was granted by the University of Cape Town\u2019s Human Research Ethics Committee (HREC REF:654\/2016). Participation in the study was voluntary and written informed consent was obtained from all interviewees. Participant anonymity and confidentiality were maintained throughout data collection and analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1003"}}